ICAM1 and cancer: Clinical data establish an inverse association between the NSCLC patients overall survival and cancer expression of intercellular adhesion molecule-1 (ICAM-1) [4], a transmembrane glycoprotein belonging to the immunoglobulin (Ig) superfamily of adhesion molecules.